Macular vitelliform lesion in desferrioxamine-related retinopathy

Documenta Ophthalmologica

Volumn 121, Issue 2, 2010, Pages 161-166

  Genead, Mohamed A ^a   Fishman, Gerald A ^a   Anastasakis, Anastasios ^a   Lindeman, Martin ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Desferrioxamine toxicity; Electroretinogram measurement; Macular vitelliform lesion

Indexed keywords

DEFEROXAMINE;

ADULT; ANAMNESIS; ARTICLE; AUTOFLUORESCENCE; BLOOD TRANSFUSION; CASE REPORT; CLINICAL FEATURE; ELECTROPHYSIOLOGY; ELECTRORETINOGRAM; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; OPTICAL COHERENCE TOMOGRAPHY; PERIMETRY; PRIORITY JOURNAL; PSYCHOPHYSIOLOGY; RETINA CONE; RETINA MACULA VITELLIFORM DEGENERATION; RETINA PIGMENT DEGENERATION; RETINA ROD; RETINOPATHY; THALASSEMIA MAJOR; VISUAL ACUITY; VISUAL FIELD;

BETA-THALASSEMIA; DEFEROXAMINE; ELECTRORETINOGRAPHY; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; MIDDLE AGED; RETINAL DISEASES; SIDEROPHORES; VISUAL ACUITY; VISUAL FIELD TESTS; VISUAL FIELDS;

EID: 77957665201     PISSN: 00124486     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10633-010-9236-z     Document Type: Article

References (18)

1. JB Porter 1997 A risk-benefit assessment of iron-chelation therapy Drug Saf 17 407 421 1:CAS:528:DyaK1cXhvFOlsw%3D%3D 10.2165/00002018-199717060-00006 9429839
2. V Lakhanpal SS Schocket R Jiji 1984 Deferoxamine (Desferal)-induced toxic retinal pigmentary degeneration and presumed optic neuropathy Ophthalmology 91 443 451 1:STN:280:DyaL2c3ks1Oqsg%3D%3D 6739047
3. SC Davies RE Marcus JL Hungerford MH Miller GB Arden ER Huehns 1983 Ocular toxicity of high-dose intravenous desferrioxamine Lancet 2 181 184 1:STN:280:DyaL3s3ktlKnsA%3D%3D 10.1016/S0140-6736(83)90170-8 6135026
4. RB Orton LL de Veber HM Sulh 1985 Ocular and auditory toxicity of long-term, high-dose subcutaneous Deferoxamine therapy Can J Ophthalmol 20 153 156 1:STN:280:DyaL28%2FislCkuw%3D%3D 4052864
5. A Cases J Kelly F Sabater A Torras MC Griño J Lopez-Pedret L Revert 1990 Ocular and auditory toxicity in hemodialyzed patients receiving desferrioxamine Nephron 56 19 23 1:STN:280:DyaK3M%2Fktlejsg%3D%3D 10.1159/000186094 2234245
6. AM Mehta RE Engstrom Jr AE Kreiger 1994 Deferoxamine associated retinopathy after subcutaneous injection [letter] Am J Ophthalmol 118 260 262 1:STN:280:DyaK2czjtVCruw%3D%3D 8053479
7. S De Virgiliis M Congia MP Turco F Frau C Dessi F Argiolu R Sorcinelli A Sitzia A Cao 1988 Depletion of trace elements and acute ocular toxicity induced by desferrioxamine in patients with thalassaemia Arch Dis Child 63 250 255 10.1136/adc.63.3.250 3355204
8. A Cohen M Martin J Mizanin DF Konkle E Schwartz 1990 Vision and hearing during deferoxamine therapy J Pediatr 117 326 330 1:STN:280:DyaK3czjvFagsA%3D%3D 10.1016/S0022-3476(05)80556-6 2380834
9. R Haimovici DJ D'Amico ES Gragoudas S Sokol 2002 The expanded clinical spectrum of deferoxamine retinopathy Ophthalmology 109 164 171 10.1016/S0161-6420(01)00947-2 11772599
10. V Bansal I Elgarbly FD Ghanchi PL Atkinson 2003 Bull's eye maculopathy with deferoxamine Eur J Haematol 70 6 420 421 1:STN:280:DC%2BD3s3jtlymsA%3D%3D 10.1034/j.1600-0609.2003.00073.x 12756028
11. MF Marmor AB Fulton GE Holder Y Miyake M Brigell M Bach 2009 ISCEV Standard for full-field clinical electroretinography (2008 update) Doc Ophthalmol 118 69 77 1:STN:280:DC%2BD1M%2FnvVGjsQ%3D%3D 10.1007/s10633-008-9155- 4 19030905
12. H Pall DR Blake P Winyard J Lunec A Williams PA Good EE Kritzinger A Cornish RC Hider 1989 Ocular toxicity of desferrioxamine-an example of copper promoted auto-oxidative damage? Br J Ophthalmol 73 42 47 1:STN:280: DyaL1M7ltVahsg%3D%3D 10.1136/bjo.73.1.42 2784062
13. TB Chaston DR Richardson 2003 Iron chelators for the treatment of iron overload disease: relationship between structure, redox activity, and toxicity Am J Hematol 73 200 210 1:CAS:528:DC%2BD3sXmtFWjtbk%3D 10.1002/ajh.10348 12827659
14. CR Gonzales AP Lin RE Engstrom AE Kreiger 2004 Bilateral vitelliform maculopathy and deferoxamine toxicity Retina 24 3 464 467 10.1097/00006982- 200406000-00024 15187676
15. GB Arden B Wonke C Kennedy ER Huehns 1984 Ocular changes in patients undergoing long-term desferrioxamine treatment Br J Ophthalmol 68 12 873 877 1:STN:280:DyaL2M%2Fnt1Oltw%3D%3D 10.1136/bjo.68.12.873 6509007
16. C Jiang RM Hansen BE Gee SS Kurth AB Fulton 1999 Rod and rod mediated function in patients with beta-thalassemia major Doc Ophthalmol 96 4 333 345 1:STN:280:DC%2BD3czht1GitQ%3D%3D 10.1023/A:1001728512515
17. Roulez F (2007) Retinal pigment epithelium-desferal. Bull Soc Belge Ophtalmol (304):59-66
18. C Bene A Manzler D Bene G Kranias 1989 Irreversible ocular toxicity from single "challenge" dose of deferoxamine Clin Nephrol 31 1 45 48 1:STN:280:DyaL1M7hvFyksQ%3D%3D 2783668